Badimon J J, Fuster V, Chesebro J H, Badimon L
Cardiac Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
Circulation. 1993 Mar;87(3 Suppl):II3-16.
Several of the theories on the pathogenesis of atherosclerosis may be integrated into a single multifactorial one. According to this theory, the most likely sequence of events involved in early atherosclerosis is vascular dysfunction and/or injury, monocyte recruitment and macrophage formation, lipid deposition, vascular smooth muscle cell proliferation (mitogenic factor mediated), and synthesis of extracellular matrix. The interaction of all these factors will configurate the typical characteristic of the atherosclerotic plaque.
Accumulating experimental and clinical data suggest two pathways in atherosclerotic progression. In some cases, the very slow process of the pathogenesis of early lesions may be significantly accelerated by means of thrombus formation and organization. Thrombosis is a key process in the pathogenesis of late atherogenesis and in the development of acute ischemic syndromes.
The possibility of retarding human atherosclerosis or even inducing its regression is one of the present therapeutic challenges. Of the different approaches to this question, one approach aims at better control of risk factors, especially plasma lipid levels. Another approach attempts to enhance the removal of lipids from the arterial wall by increasing plasma high density lipoprotein levels. Each of these approaches, by acting on the lipid-rich plaques more prone to rupture, might prevent plaque progression and induce regression to prevent acute coronary events. A third approach, based on the key role of platelet thrombus formation in the conversion of chronic to acute events, would be the use of antithrombotic therapy. This last approach may partially prevent progression of the disease.
动脉粥样硬化发病机制的几种理论可能整合为一个单一的多因素理论。根据该理论,早期动脉粥样硬化最可能的事件序列是血管功能障碍和/或损伤、单核细胞募集和巨噬细胞形成、脂质沉积、血管平滑肌细胞增殖(有丝分裂原介导)以及细胞外基质合成。所有这些因素的相互作用将构成动脉粥样硬化斑块的典型特征。
越来越多的实验和临床数据表明动脉粥样硬化进展存在两条途径。在某些情况下,早期病变发病机制非常缓慢的过程可能会通过血栓形成和机化而显著加速。血栓形成是晚期动脉粥样硬化发病机制和急性缺血综合征发生发展中的关键过程。
延缓人类动脉粥样硬化甚至使其逆转的可能性是当前治疗面临的挑战之一。针对这个问题的不同方法中,一种方法旨在更好地控制危险因素,尤其是血浆脂质水平。另一种方法试图通过提高血浆高密度脂蛋白水平来增强从动脉壁清除脂质的能力。这些方法中的每一种,通过作用于更易破裂的富含脂质的斑块,可能预防斑块进展并诱导其逆转以预防急性冠状动脉事件。第三种方法基于血小板血栓形成在慢性事件向急性事件转化中的关键作用,即使用抗血栓治疗。最后这种方法可能部分预防疾病进展。